Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Genmab A/S
SWB:GE9
Genmab A/S
SWB:GE9
Price:
254.5
EUR
0.71%
Market Closed
Market Cap:
€16.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Genmab A/S
SWB:GE9
|
DK |
|
F
|
Five Below Inc
F:6F1
|
US |
|
M
|
Mitsui & Co Ltd
XMUN:MTS1
|
JP |
|
S
|
Samrat Forgings Ltd
BSE:543229
|
IN |
|
Indofarma Tbk PT
IDX:INAF
|
ID |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
DUS:ME9
|
IT |
|
F
|
Fu Burg Industrial Co Ltd
TPEX:8929
|
TW |
|
Kurabo Industries Ltd
TSE:3106
|
JP |
|
Black Bird Biotech Inc
OTC:BBBT
|
US |
|
G
|
G Medical Innovations Holdings Ltd
OTC:GMVDF
|
IL |
|
O
|
Obsidian Energy Ltd
F:P13A
|
CA |
|
L
|
Lyft Inc
SWB:LY0
|
US |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
E
|
Encompass Health Corp
SWB:HSOA
|
US |
|
WEG SA
BOVESPA:WEGE3
|
BR |
|
Coppermoly Ltd
ASX:COY
|
AU |
|
Grid Battery Metals Inc
XTSX:CELL
|
CA |
|
Tower Resources PLC
LSE:TRP
|
UK |
|
Tenaris SA
BMV:TS
|
LU |
|
Widodo Makmur Unggas Tbk PT
IDX:WMUU
|
ID |
Wall St Price Targets
GE9 Price Forecast
Based on 20 analysts
Based on 20 analysts
+33% Upside
from
€254.5
today
Genmab A/S (GE9)’s 12-month stock price forecast through August 2027 has a consensus target of €338.68, implying 33% upside. The forecast is based on price targets from 20 Wall Street analysts.
GE9 Analyst Rating
No ratings yet
No ratings yet
Genmab A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GE9's stock price target?
Price Target
338.68
EUR
338.68
EUR
According to Wall Street analysts, the average 1-year price target for GE9 is 338.68 EUR with a low forecast of 187.8 EUR and a high forecast of 557.82 EUR.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
20%
20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.